Enovis Corporation beats top-line and bottom-line estimates; updates FY25 outlook

* Enovis Corporation press release [https://seekingalpha.com/pr/20296140-enovis-announces-third-quarter-2025-results] (ENOV [https://seekingalpha.com/symbol/ENOV]): Q3 Non-GAAP EPS of $0.75 beats by $0.10.
* Revenue of $549M (+8.7% Y/Y) beats by $10.39M.
*
2025 FINANCIAL OUTLOOK

Enovis updated financial expectations for 2025. Revenue is expected to be in the range of $2.24-2.27 billion, versus prior expectations of $2.245-2.275 billion VS. CONSENSUS OF $2.25B. Updated guidance includes a $15 million revenue reduction attributable to the Dr. Comfort divestiture completed in October 2025. Adjusted EBITDA is forecasted to be $395-405 million, as compared to the prior outlook of $392-402 million. Full-year adjusted earnings per share guidance was updated from $3.05-3.20 to $3.10-3.25 VS. CONSENSUS OF $3.13.

MORE ON ENOVIS CORPORATION

* Enovis: Healthy Recon Trends Vs. Market Apathy [https://seekingalpha.com/article/4817080-enovis-stock-healthy-recon-trends-vs-market-apathy]
* Enovis Corporation Q3 2025 Earnings Preview [https://seekingalpha.com/news/4516065-enovis-corporation-q3-2025-earnings-preview]
* Seeking Alpha’s Quant Rating on Enovis Corporation [https://seekingalpha.com/symbol/ENOV/ratings/quant-ratings]
* Historical earnings data for Enovis Corporation [https://seekingalpha.com/symbol/ENOV/earnings]
* Financial information for Enovis Corporation [https://seekingalpha.com/symbol/ENOV/income-statement]